2022
DOI: 10.1099/jmm.0.001585
|View full text |Cite
|
Sign up to set email alerts
|

mgpB genotyping and genetic diversity for antimicrobial resistance of Mycoplasma genitalium

Abstract: Introduction. Antimicrobial resistance (AMR) among Mycoplasma genitalium is a global issue. Understanding the transmission dynamics of infection is an important factor in reducing the occurrence of AMR. Hypothesis/Gap Statement. There is limited information on the genotyping and AMR traits of M. genitalium … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 19 publications
(110 reference statements)
0
2
0
Order By: Relevance
“…In Korea, the domestic prevalence of macrolide-resistant M. genitalium is still low compared to other countries, but fluoroquinolone resistance is high [ 27 28 ]. However, due to the increased prevalence of macrolide resistance worldwide, all M. genitalium positive specimens should be traced on an assay capable of detecting macrolide-resistant mutations.…”
Section: Resultsmentioning
confidence: 99%
“…In Korea, the domestic prevalence of macrolide-resistant M. genitalium is still low compared to other countries, but fluoroquinolone resistance is high [ 27 28 ]. However, due to the increased prevalence of macrolide resistance worldwide, all M. genitalium positive specimens should be traced on an assay capable of detecting macrolide-resistant mutations.…”
Section: Resultsmentioning
confidence: 99%
“…If M. genitalium infects the prostate through the urethra, its intracellular location and limited treatment options make successful eradication challenging, potentially resulting in chronic infections. Indeed, relapse or recurrent infections with the same genotype of M. genitalium infection were frequently observed in clinical practices after targeted antimicrobial therapies [6,14].…”
Section: Introductionmentioning
confidence: 99%